Stay updated on LAP of Mepolizumab for MEA115921 Participants Clinical Trial
Sign up to get notified when there's something new on the LAP of Mepolizumab for MEA115921 Participants Clinical Trial page.

Latest updates to the LAP of Mepolizumab for MEA115921 Participants Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; deleted the funding-lapse notice and Revision: v3.4.1. No study content changes are present.SummaryDifference0.3%

- Check21 days agoChange DetectedNotice of government funding lapse and an updated Revision: v3.4.1 were added; no changes to core study content or data are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a glossary display, introduced a QC status field (Last Update Submitted that Met QC Criteria), and updated the page revision to v3.4.0. Removed the older No FEAR Act data label and the previous revision text (v3.3.4).SummaryDifference0.2%

- Check42 days agoChange DetectedThe page shows a minor administrative revision tag update from v3.3.3 to v3.3.4 without changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations were expanded with new sites across the US, Canada, and Europe. The page revision is now v3.3.3.SummaryDifference2%

- Check92 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2, reflecting an administrative update rather than content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to LAP of Mepolizumab for MEA115921 Participants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LAP of Mepolizumab for MEA115921 Participants Clinical Trial page.